Supportive Care (for active infection)
Treatment for Yellow fever
Typical Dosage: Varies (e.g., IV fluids, paracetamol, oxygen support)
Effectiveness
70%
Safety Score
85%
Clinical Trials
1,000
Participants
1M
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
85
DangerousModerateSafe
Treatment Details
Dosage Range
Varies (e.g., IV fluids, paracetamol, oxygen support)
Time to Effect
Immediate for symptom relief
Treatment Duration
1-2 weeks (duration of acute illness)
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,000
Monitoring:$45,000
Side Effect Mgmt:$1,000
Total Annual:$48,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$3,333/QALY
QALYs Gained
15
Outcome-Based Costs
Cost per Responder
$80,000
Supportive Care (for active infection) Outcomes
for Yellow fever
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+60%
Common Side Effects
Fluid overload
+1%
Electrolyte imbalance
+2%
Adverse drug reactions (e.g., from antipyretics, antibiotics)
+5%
Complications from organ support (e.g., dialysis, intubation)
+3%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov